FDA Approves Farxiga to Improve Glycemic Control in Pediatric Patients with Type 2 Diabetes
AstraZeneca’s Farxiga has previously been approved by the FDA as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, in addition to indications for heart failure.